Clinical trial Recruiting at 10 sites Observational Ages 18 to 70

Examining the impact of Nociscan on back pain surgery outcomes

Official title: A Multi-Center Randomized Clinical Study of the NOCISCAN MR Spectroscopy (MRS) in Patients Treated for Discogenic Low Back Pain

Run by Aclarion · NCT06661850 · Data updated 2026-11-12

This study is testing if a new software tool called Nociscan can help improve surgery results for people with low back pain by better identifying which discs are causing pain.

More Low Back Pain trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment300 (estimated)
SponsorAclarion
Industry-sponsored
Locations10 sites (Phoenix, Arizona and 9 other locations)
StatusRecruiting
StartedJune 11, 2025
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 10, 2026
Trial IDNCT06661850 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are skeletally mature adults aged 18 to 70 with a primary diagnosis of discogenic low back pain who have not responded to at least six months of non-operative treatment.

Probably not a fit

Patients who are not planning to undergo surgical treatment for their back pain or those with non-degenerative causes of back pain may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the safety and effectiveness of Nociscan, a software tool that utilizes Magnetic Resonance (MR) spectroscopy to help differentiate between painful and nonpainful discs in the lumbar spine. The study will compare surgical outcomes of patients who receive Nociscan reports prior to treatment against those who do not, using both blinded and unblinded cohorts. Participants will be individuals scheduled for surgery due to discogenic low back pain, and their outcomes will be assessed based on the Nociscan findings.

Why it matters

Potential benefit: If successful, this study could enhance surgical decision-making for patients with discogenic low back pain, potentially leading to better outcomes.

How similar studies have gone: While this approach is innovative, similar studies utilizing MR spectroscopy for pain differentiation have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject is a skeletally mature male or female (non-pregnant) aged 18 to 70 years (inclusive);
2. Subject intends to undergo instrumented surgical treatment in the lumbar spinal disc for their lower back pain, independent of this research protocol;
3. Subject is to be treated with FDA-cleared or FDA-approved devices independent of this research protocol;
4. Subject has a preoperative Oswestry Disability Questionnaire score ≥35 out of 100 points (35/100);
5. Subject has a VAS back pain score of ≥40mm;
6. Subject has failed at least ≥ 6 months of non-operative treatment (for example: physical therapy, bed rest, anti-inflammatory or analgesic medications, chiropractic care, acupuncture, massage therapy or home-directed lumbar exercise programs) OR requires urgent surgical treatment per the investigator;
7. Subject has signed the IRB approved Informed Consent Form; and
8. Subject is psychosocially, mentally and physically able and willing to fully comply with this protocol including adhering to follow-up schedule and requirements and filling out forms.

Exclusion Criteria:

1. Subject has had prior lumbar back surgery or intradiscal treatments at any lumbar level (Note: diagnostic provocative or anesthetic discography are not excluded; micro-discectomy, decompression, or laminectomy patients greater than 6 months postop are not excluded);
2. Subject has a lumbar spine diagnosis, based on radiographic evidence, of clinically relevant lumbar vertebral abnormalities (except Modic end-plate changes, which are not excluded), including:

   * Grade 3 Spondylolisthesis (Grade 1 or Grade 2 is allowed)
   * Pars fracture, at the involved level
   * Spondylolysis
   * Lumbar scoliosis with a Cobb angle of greater than 20°
   * Evidence of prior fracture or trauma to the L1, L2, L3, L4, or L5 levels in either compression or burst
   * Lumbar kyphosis
3. Subject is contraindicated for a standard lumbar MRI exam
4. Women who are currently pregnant (or believe they may be at risk of being or becoming pregnant), or are breast feeding, during the study period when scans will be performed
5. Subject has a chronic disease (other than degenerative disc disease), chronic pain (other than low back pain), or psychological dysfunction, which may, in the opinion of the Principal Investigator, compromise a subject's ability to comply with study procedures, and/or may confound data

Where it's running

  • University of Arizona
    Phoenix, Arizona, United States
    Recruiting
  • Todd H. Lanman, M.D Inc
    Beverly Hills, California, United States
    Recruiting
  • Scripps Health
    La Jolla, California, United States
    Recruiting
  • USC Keck Medical Center
    Los Angeles, California, United States
    Recruiting
  • University of Miami/ Jackson Health System
    Miami, Florida, United States
    Recruiting
  • Northwestern University
    Chicago, Illinois, United States
    Recruiting
Show 4 more locations
  • Endeavor Health
    Evanston, Illinois, United States
    Recruiting
  • Advocate Aurora Research Institute
    Park Ridge, Illinois, United States
    Recruiting
  • Johns Hopkins Medicine
    Baltimore, Maryland, United States
    Recruiting
  • Texas Back Institute
    Plano, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.